Aldehyde dehydrogenase 7A1 (ALDH7A1) functions in lysine catabolism by catalyzing the NAD + -dependent oxidation of α-aminoadipate semialdehyde to α-aminoadipate. Initial insolution and in crystallo structural studies of ALDH7A1 suggested a static tetrameric assembly.
However, more detailed analysis by analytical ultracentrifugation (AUC) revealed ALDH7A1 exists in a dimer-tetramer equilibrium with a modest dissociation constant (16 µM) (1). Recent results also suggest the oligomeric state of ALDH7A1 is dramatically influenced by a mobile Cterminus and the binding of active site ligands. These new findings have implications for understanding the molecular basis of the autosomal recessive seizure disorder pyridoxinedependent epilepsy (PDE), which is caused by mutations in the ALDH7A1 gene. Many PDElinked mutations target residues in the C-terminus and oligomeric interfaces of ALDH7A1, implying that disease states may result from disruption of the self-association equilibrium.
Herein we will describe an integrative biophysical and structural study utilizing SEC-MALS-SAXS, AUC, and electron microscopy to probe the oligomeric states of wild-type ALDH7A1 and several disease-linked variants. Analysis of the in-solution oligomeric behavior of a Cterminal deletion mutant lacking the last 8 residues revealed a dramatically perturbed selfassociation equilibrium and introduced the possibility of a trimeric assembly, which has not previously been identified in aldehyde dehydrogenases (2) . In addition, a number of PDE-linked variants result in formation of potentially trimeric species in solution. Overall, studies of both laboratory and PDE-related mutations in ALDH7A1 have revealed a connection linking catalytic activity and oligomeric state. These results add to a growing body of research suggesting that disease-related mutations propagate inactive oligomers that sequester inactive enzymes.
